Actinium Pharmaceuticals Applauds CancerCare for Launching the First Ever Acute Myeloid Leukemia Awareness Month
Actinium Pharmaceuticals, Inc.("Actinium" or the "Company"), a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of patients with advanced cancers, applauds CancerCare for their work to make June 2016 the first ever Acute Myeloid Leukemia (AML) Awareness Month. Throughout AML Awareness Month, CancerCare will feature educational information for the AML community that can be accessed via CancerCare's website (www.cancercare.org/amlaware) as well as social media efforts to raise awareness for AML.
View full press release